Lucas S, Hoffman JM, Bell KR, andDikmen S (2014) A prospective study of prevalence and characterization of headache following mild traumatic brain injury Cephalalgia. 34:93–102. https://doi.org/10.1177/0333102413499645

Brown AW, Watanabe TK, Hoffman JM, Bell KR, Lucas S, andDikmen S (2015) Headache after traumatic brain injury: a national survey of clinical practices and treatment approaches PM R 7. 3–8. https://doi.org/10.1016/j.pmrj.2014.06.016

Ashina H, Porreca F, Anderson T, Amin FM, Ashina M, Schytz HW et al (2019) Post-traumatic headache: epidemiology and pathophysiological insights. Nat Rev Neurol 15:607–617. https://doi.org/10.1038/s41582-019-0243-8

Article  PubMed  Google Scholar 

Moskowitz MA, Reinhard JF Jr., Romero J, Melamed E, andPettibone DJ (1979) Neurotransmitters and the fifth cranial nerve: is there a relation to the headache phase of migraine? Lancet 2:883–885. https://doi.org/10.1016/s0140-6736(79)92692-8

Article  CAS  PubMed  Google Scholar 

Tanaka M, andZhang Y (2022) Preclinical studies of Posttraumatic Headache and the potential therapeutics cells. 12. https://doi.org/10.3390/cells12010155

Guo Z, Czerpaniak K, Zhang J, andCao YQ (2021) Increase in trigeminal ganglion neurons that respond to both calcitonin gene-related peptide and pituitary adenylate cyclase-activating polypeptide in mouse models of chronic migraine and posttraumatic headache Pain. 162:1483–1499. https://doi.org/10.1097/j.pain.0000000000002147

Lu ZX, Dong BQ, Wei HL, andChen L (2022) Prediction and associated factors of non-steroidal anti-inflammatory drugs efficacy in migraine treatment front Pharmacol. 13:1002080. https://doi.org/10.3389/fphar.2022.1002080

Visser WH, de Vriend RH, Jaspers NH, andFerrari MD (1996) Sumatriptan-nonresponders: a survey in 366 migraine patients Headache. 36:471–475. https://doi.org/10.1046/j.1526-4610.1996.3608471.x

Porreca F, Navratilova E, Hirman J, van den Brink AM, Lipton RB, andDodick DW (2024) Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex Cephalalgia. 44:3331024241238153. https://doi.org/10.1177/03331024241238153

Russo AF, andHay DL (2023) CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond. Physiol Rev 103:1565–1644. https://doi.org/10.1152/physrev.00059.2021

Article  CAS  PubMed  Google Scholar 

Donvito G, Nass SR, Wilkerson JL, Curry ZA, Schurman LD, Kinsey SG et al (2018) The endogenous cannabinoid system: a budding source of targets for treating Inflammatory and Neuropathic Pain Neuropsychopharmacology. 43:52–79. https://doi.org/10.1038/npp.2017.204

Greco R, Demartini C, Francavilla M, Zanaboni AM, andTassorelli C (2021) Dual inhibition of FAAH and MAGL counteracts migraine-like Pain and Behavior in an animal. Model Migraine Cells 10. https://doi.org/10.3390/cells10102543

Tchantchou F, Tucker LB, Fu AH, Bluett RJ, McCabe JT, Patel S et al (2014) The fatty acid amide hydrolase inhibitor PF-3845 promotes neuronal survival, attenuates inflammation and improves functional recovery in mice with traumatic brain injury neuropharmacology. 85:427–439. https://doi.org/10.1016/j.neuropharm.2014.06.006

Zhang J, Teng Z, Song Y, Hu M, andChen C (2015) Inhibition of monoacylglycerol lipase prevents chronic traumatic encephalopathy-like neuropathology in a mouse model of repetitive mild closed head injury. J Cereb Blood Flow Metab 35:706. https://doi.org/10.1038/jcbfm.2014.247

Article  CAS  PubMed  PubMed Central  Google Scholar 

Selvaraj P, Tanaka M, Wen J, andZhang Y (2021) The Novel Monoacylglycerol lipase inhibitor MJN110 suppresses Neuroinflammation, normalizes synaptic composition and improves behavioral performance in the repetitive traumatic brain Injury. Mouse Model Cells 10. https://doi.org/10.3390/cells10123454

Wen J, Sackett S, Tanaka M, andZhang Y (2023) Therapeutic effects of Combined Treatment with the AEA hydrolysis inhibitor PF04457845 and the substrate selective COX-2 inhibitor LM4131 in the mouse model of Neuropathic Pain cells. 12. https://doi.org/10.3390/cells12091275

Savinainen JR, Saario SM, andLaitinen JT (2012) The serine hydrolases MAGL, ABHD6 and ABHD12 as guardians of 2-arachidonoylglycerol signalling through cannabinoid receptors. Acta Physiol (Oxf) 204:267–276. https://doi.org/10.1111/j.1748-1716.2011.02280.x

Article  CAS  PubMed  Google Scholar 

Herkenham M, Lynn AB, Little MD, Johnson MR, Melvin LS, de Costa BR et al (1990) Cannabinoid receptor localization in brain. Proc Natl Acad Sci U S A 87:1932–1936. https://doi.org/10.1073/pnas.87.5.1932

Article  CAS  PubMed  PubMed Central  Google Scholar 

Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K et al (2005) Identification and functional characterization of brainstem cannabinoid CB2 receptors Science. 310:329–332. https://doi.org/10.1126/science.1115740

Sun J, Zhou YQ, Chen SP, Wang XM, Xu BY, Li DY et al (2019) The endocannabinoid system: novel targets for treating cancer induced bone pain Biomed Pharmacother. 120:109504. https://doi.org/10.1016/j.biopha.2019.109504

Ghosh S, Kinsey SG, Liu QS, Hruba L, McMahon LR, Grim TW et al (2015) Full fatty acid Amide Hydrolase Inhibition combined with partial Monoacylglycerol lipase inhibition: augmented and sustained Antinociceptive effects with reduced Cannabimimetic Side effects in mice. J Pharmacol Exp Ther 354:111–120. https://doi.org/10.1124/jpet.115.222851

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tassorelli C, Greco R, andSilberstein SD (2019) The endocannabinoid system in migraine: from bench to pharmacy and back. Curr Opin Neurol 32:405–412. https://doi.org/10.1097/WCO.0000000000000688

Article  CAS  PubMed  Google Scholar 

Sarchielli P, Pini LA, Coppola F, Rossi C, Baldi A, Mancini ML et al (2007) Endocannabinoids in chronic migraine: CSF findings suggest a system failure Neuropsychopharmacology 32, 1384–1390 https://doi.org/10.1038/sj.npp.1301246

Greco R, Demartini C, Zanaboni AM, Piomelli D, andTassorelli C (2018) Endocannabinoid System and Migraine Pain: an Update Front Neurosci. 12:172. https://doi.org/10.3389/fnins.2018.00172

Russo EB (2016) Clinical Endocannabinoid Deficiency reconsidered: current research supports the theory in Migraine, Fibromyalgia, irritable bowel, and other treatment-resistant syndromes Cannabis Cannabinoid Res. 1:154–165. https://doi.org/10.1089/can.2016.0009

Della Pietra A, Giniatullin R, andSavinainen JR (2021) Distinct activity of Endocannabinoid-Hydrolyzing Enzymes MAGL and FAAH in Key regions of Peripheral and Central Nervous System implicated in Migraine. Int J Mol Sci 22. https://doi.org/10.3390/ijms22031204

Bree D, andLevy D (2018) Strides toward Better Understanding of Post-traumatic headache pathophysiology using animal models Curr Pain Headache Rep. 22:67. https://doi.org/10.1007/s11916-018-0720-6

Benemei S, Labastida-Ramirez A, Abramova E, Brunelli N, Caronna E, Diana P et al (2020) Persistent post-traumatic headache: a migrainous loop or not? The preclinical evidence. J Headache Pain 21:90. https://doi.org/10.1186/s10194-020-01135-0

Article  PubMed  PubMed Central  Google Scholar 

Benromano T, Defrin R, Ahn AH, Zhao J, Pick CG, andLevy D (2015) Mild closed head injury promotes a selective trigeminal hypernociception: implications for the acute emergence of post-traumatic headache. Eur J Pain 19:621–628. https://doi.org/10.1002/ejp.583

Article  CAS  PubMed  Google Scholar 

Elliott MB, Oshinsky ML, Amenta PS, Awe OO, andJallo JI (2012) Nociceptive neuropeptide increases and periorbital allodynia in a model of traumatic brain injury headache. 52:966–984. https://doi.org/10.1111/j.1526-4610.2012.02160.x

Feliciano DP, Sahbaie P, Shi X, Klukinov M, Clark JD, andYeomans DC (2014) Nociceptive sensitization and BDNF up-regulation in a rat model of traumatic brain injury Neurosci Lett. 583:55–59. https://doi.org/10.1016/j.neulet.2014.09.030

Namjoshi DR, Cheng WH, McInnes KA, Martens KM, Carr M, Wilkinson A et al (2014) Merging pathology with biomechanics using CHIMERA (closed-Head Impact Model of Engineered Rotational Acceleration): a novel, surgery-free model of traumatic brain injury Mol Neurodegener. 9. https://doi.org/10.1186/1750-1326-9-55

McNamara EH, Grillakis AA, Tucker LB, McCabe JT (2020) The closed-head impact model of engineered rotational acceleration (CHIMERA) as an application for traumatic brain injury pre-clinical research: A status report. Exp Neurol. 333:113409.

Niphakis MJ, Cognetta AB 3rd, Chang JW, Buczynski MW, Parsons LH, Byrne F et al (2013) Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors. ACS Chem Neurosci 4:1322–1332. https://doi.org/10.1021/cn400116z

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ignatowska-Jankowska B, Wilkerson JL, Mustafa M, Abdullah R, Niphakis M, Wiley JL et al (2015) Selective monoacylglycerol lipase inhibitors: antinociceptive versus cannabimimetic effects in mice. J Pharmacol Exp Ther 353:424–432. https://doi.org/10.1124/jpet.114.222315

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chaplan SR, Bach FW, Pogrel JW, Chung JM, andYaksh TL (1994) Quantitative assessment of tactile allodynia in the rat paw. J Neurosci Methods 53:55–63. https://doi.org/10.1016/0165-0270(94)90144-9

Article  CAS  PubMed  Google Scholar 

De Logu F, Landini L, Janal MN, Li Puma S, De Cesaris F, Geppetti P et al (2019) Migraine-provoking substances evoke periorbital allodynia in mice. J Headache Pain 20. https://doi.org/10.1186/s10194-019-0968-1

Smits H, Ultenius C, Deumens R, Koopmans GC, Honig WM, van Kleef M et al (2006) Effect of spinal cord stimulation in an animal model of neuropathic pain relates to degree of tactile allodynia. Neuroscience 143:541–546. https://doi.org/10.1016/j.neuroscience.2006.08.007

Article  CAS  PubMed  Google Scholar 

Bree D, andLevy D (2018) Development of CGRP-dependent pain and headache related behaviours in a rat model of concussion: implications for mechanisms of post-traumatic headache Cephalalgia. 38:246–258. https://doi.org/10.1177/0333102416681571

Navratilova E, Rau J, Oyarzo J, Tien J, Mackenzie K, Stratton J et al (2019) CGRP-dependent and independent mechanisms of acute and persistent post-traumatic headache following mild traumatic brain injury in mice Cephalalgia. 39:1762–1775. https://doi.org/10.1177/0333102419877662

Wattiez AS, Castonguay WC, Gaul OJ, Waite JS, Schmidt CM, Reis AS et al (2021) Different forms of traumatic brain injuries cause different tactile hypersensitivity profiles Pain. 162:1163–1175. https://doi.org/10.1097/j.pain.0000000000002103

Ogasawara D, Deng H, Viader A, Baggelaar MP, Breman A, den Dulk H et al (2016) Rapid and profound rewiring of brain lipid signaling networks by acute diacylglycerol lipase inhibition. Proc Natl Acad Sci U S A 113:26–33. https://doi.org/10.1073/pnas.1522364112

Article  CAS  PubMed  Google Scholar 

Zhang Q, Han X, Wu H, Zhang M, Hu G, Dong Z et al (2019) Dynamic changes in CGRP, PACAP, and PACAP receptors in the trigeminovascular system of a novel repetitive electrical stimulation rat model: relevant to migraine Mol Pain. 15:1744806918820452. https://doi.org/10.1177/1744806918820452

Sturaro C, Fakhoury B, Targowska-Duda KM, Zribi G, Schoch J, Ruzza C et al (2023) Preclinical effects of cannabidiol in an experimental model of migraine Pain. 164:2540–2552. https://doi.org/10.1097/j.pain.0000000000002960

Araya EI, Turnes JM, Barroso AR, andChichorro JG (2020) Contribution of intraganglionic CGRP to migraine-like responses in male and female rats Cephalalgia. 40:689–700. https://doi.org/10.1177/0333102419896539

Tyburski AL, Cheng L, Assari S, Darvish K, andElliott MB (2017) Frequent mild head injury promotes trigeminal sensitivity concomitant with microglial proliferation, astrocytosis, and increased neuropeptide levels in the trigeminal pain system. J Headache Pain 18. https://doi.org/10.1186/s10194-017-0726-1

Ashina H, Iljazi A, Al-Khazali HM, Christensen CE, Amin FM, Ashina M, Schytz HW (2020) Hypersensitivity to Calcitonin Gene-Related Peptide in Post-Traumatic Headache. Ann Neurol. 88(6):1220-1228.

Ashina H, Iljazi A, Al-Khazali HM, Do TP, Eigenbrodt AK, Larsen EL, Andersen AM, Hansen KJ, Bräuner KB, Chaudhry BA, Christensen CE, Amin FM, Schytz HW (2022) CGRP-induced migraine-like headache in persistent post-traumatic headache attributed to mild traumatic brain injury. J Headache Pain. 23(1):135.

Elliott MB, Tuma RF, Amenta PS, Barbe MF, andJallo JI (2011) Acute effects of a selective cannabinoid-2 receptor agonist on neuroinflammation in a model of traumatic brain injury. J Neurotrauma 28:973–981. https://doi.org/10.1089/neu.2010.1672

Article  PubMed  Google Scholar 

Amenta PS, Jallo JI, Tuma RF, andElliott MB (2012) A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury. J Neurosci Res 90:2293–2305. https://doi.org/10.1002/jnr.23114

Article  CAS  PubMed  Google Scholar 

Howard L, andSchwedt TJ (2020) Posttraumatic headache: recent progress. Curr Opin Neurol 33:316–322. https://doi.org/10.1097/WCO.0000000000000815

Article